51 results on '"Magri, Chiara"'
Search Results
2. Immune Checkpoint Inhibitors in “Special” NSCLC Populations: A Viable Approach?
3. Genome‐wide association studies of response and side effects to the BNT162b2 vaccine in Italian healthcare workers: Increased antibody levels and side effects in carriers of the HLA‐A*03:01 allele
4. Immune Checkpoint Inhibitors in “Special” NSCLC Populations: A Viable Approach?
5. Author Correction: Assessment of haptoglobin alleles in autism spectrum disorders
6. Transcriptional Profiling of Rat Prefrontal Cortex after Acute Inescapable Footshock Stress
7. LRRK2 Kinase Inhibition Attenuates Astrocytic Activation in Response to Amyloid β1-42 Fibrils
8. Investigation on the high recurrence of the ATTRv-causing transthyretin variant Val142Ile in central Italy
9. Clinical and Histological Prognostic Factors of Recurrence and Malignant Transformation in a Large Series of Oral Potentially Malignant Disorders
10. Clinical validation of a combinatorial PharmAcogeNomic approach in major Depressive disorder: an Observational prospective RAndomized, participant and rater-blinded, controlled trial (PANDORA trial)
11. Whole Blood Transcriptome Characterization of 3xTg-AD Mouse and Its Modulation by Transcranial Direct Current Stimulation (tDCS)
12. Alterations observed in the interferon α and β signaling pathway in MDD patients are marginally influenced by cis-acting alleles
13. Evidence of an interaction between FXR1 and GSK3β polymorphisms on levels of Negative Symptoms of Schizophrenia and their response to antipsychotics
14. Investigating an in silico approach for prioritizing antidepressant drug prescription based on drug-induced expression profiles and predicted gene expression
15. RNA Editing and Modifications in Mood Disorders
16. Association study betweenHTR2Ars6313 polymorphism and early response to risperidone and olanzapine in schizophrenia patients
17. Assessment of haptoglobin alleles in autism spectrum disorders
18. Investigating an in-silico approach for prioritizing antidepressant drug prescription based on drug-induced expression profiles and predicted gene expression
19. Genetic determinants of circulating VEGF levels in major depressive disorder and electroconvulsive therapy response
20. Author Correction: A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme
21. SA43ANALYSIS OF GENETIC AND ENVIRONMENTAL CONTRIBUTION TO ALTERED GENE EXPRESSION PROFILES OBSERVED IN MAJOR DEPRESSIVE DISORDER
22. SA49THE EFFECT OF CHILDHOOD TRAUMA ON BLOOD EXPRESSION OF MED22 IN PATIENTS WITH MAJOR DEPRESSIVE DISORDER IS MEDIATED BY CIS-ACTING SNPS
23. F49GENETIC DETERMINANTS OF CIRCULATING VEGF LEVELS IN MAJOR DEPRESSIVE DISORDER
24. Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables
25. A novel homozygous mutation in GAD1 gene described in a schizophrenic patient impairs activity and dimerization of GAD67 enzyme
26. The effect of childhood trauma on blood transcriptome expression in major depressive disorder
27. Genome-wide analysis of consistently RNA edited sites in human blood reveals interactions with mRNA processing genes and suggests correlations with cell types and biological variables
28. Compound heterozygosity for a hemizygous rare missense variant (rs141999351) and a large CNV deletion affecting the FSTL5 gene in a patient with schizophrenia
29. Exome sequencing in schizophrenic patients with high levels of homozygosity identifies novel and extremely rare mutations in the GABA/glutamatergic pathways
30. SNP array and FISH analysis of a proband with a 22q13.2- 22qter duplication shed light on the molecular origin of the rearrangement
31. Meta-analysis of Genome-wide Association Studies for Neuroticism, and the Polygenic Association With Major Depressive Disorder
32. Copy number variants in attention-deficit hyperactive disorder
33. De novo 1Mb interstitial deletion of 8p22 in a patient with slight mental retardation and speech delay
34. ROLE OF ALLELIC VARIANTS OF FK506-BINDING PROTEIN 51 (FKBP5) GENE IN THE DEVELOPMENT OF ANXIETY DISORDERS
35. Combined DOCK8 and CLEC7A mutations causing immunodeficiency in 3 brothers with diarrhea, eczema, and infections
36. Analysis of complete mitochondrial genomes of patients with schizophrenia and bipolar disorder
37. De novo deletion of chromosome 2q24.2 region in a mentally retarded boy with muscular hypotonia
38. New Copy Number Variations in Schizophrenia
39. ITGB2 mutation combined with deleted ring 21 chromosome in a child with leukocyte adhesion deficiency
40. Association study and mutational screening of SYNGR1 as a candidate susceptibility gene for schizophrenia
41. "GenotypeColour™": colour visualisation of SNPs and CNVs
42. Study on GRIA2, GRIA3 and GRIA4 genes highlights a positive association between schizophrenia and GRIA3 in female patients
43. Mitochondrial DNA haplogroups and age at onset of schizophrenia
44. Glutamate AMPA receptor subunit 1 gene (GRIA1) and DSM‐IV‐TR schizophrenia: A pilot case‐control association study in an Italian sample
45. Saami and Berbers—An Unexpected Mitochondrial DNA Link
46. The Molecular Dissection of mtDNA Haplogroup H Confirms That the Franco-Cantabrian Glacial Refuge Was a Major Source for the European Gene Pool
47. Phylogeography of Y-Chromosome Haplogroup I Reveals Distinct Domains of Prehistoric Gene Flow in Europe
48. Origin, Diffusion, and Differentiation of Y-Chromosome Haplogroups E and J: Inferences on the Neolithization of Europe and Later Migratory Events in the Mediterranean Area
49. From surnames to the history of Y chromosomes: the Sardinian population as a paradigm
50. Mitochondrial DNA Haplogroups Do Not Play a Role in the Variable Phenotypic Presentation of the A3243G Mutation
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.